Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy
NCT04951921
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
DRUG:
Hyperpolarized 13C Pyruvate
Sponsor
Chang Gung Memorial Hospital
Collaborators
[object Object]